A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes

Mahmoud I. Abdel-Aziz, Susanne J.H. Vijverberg, Anne H. Neerincx, Paul Brinkman, Ariane H. Wagener, John H. Riley, Ana R. Sousa, Stewart Bates, Scott S. Wagers, Bertrand De Meulder, Charles Auffray, Åsa M. Wheelock, Aruna T. Bansal, Massimo Caruso, Pascal Chanez, Mohib Uddin, Julie Corfield, Ildiko Horvath, Norbert Krug, Jacek Musial, Kai Sun, Dominick E. Shaw, Thomas Sandström, Paolo Montuschi, Stephen J. Fowler, René Lutter, Ratko Djukanovic, Peter Howarth, Paul Skipp, Marek Sanak, Ian M. Adcock, Kian Fan Chung, Peter J. Sterk, Aletta D. Kraneveld, Anke H. Maitland-van der Zee

Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mahmoud I. Abdel-Aziz, Susanne J.H. Vijverberg, Anne H. Neerincx, Paul Brinkman, Ariane H. Wagener, John H. Riley, Ana R. Sousa, Stewart Bates, Scott S. Wagers, Bertrand De Meulder, Charles Auffray, Åsa M. Wheelock, Aruna T. Bansal, Massimo Caruso, Pascal Chanez, Mohib Uddin, Julie Corfield, Ildiko Horvath, Norbert Krug, Jacek Musial, Kai Sun, Dominick E. Shaw, Thomas Sandström, Paolo Montuschi, Stephen J. Fowler, René Lutter, Ratko Djukanovic, Peter Howarth, Paul Skipp, Marek Sanak, Ian M. Adcock, Kian Fan Chung, Peter J. Sterk, Aletta D. Kraneveld, Anke H. Maitland-van der Zee. A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes. Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma
Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019
Year: 2020



Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Source: Eur Respir J 2015; 46: 688-696
Year: 2015



Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011


Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019


Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017


Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017

Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020


Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018



Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


A label-free approach to airways disease: phenotypes, endotypes and treatable traits
Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Year: 2017


The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019



The omics approach to defining endotypes and personalising treatment pathways in asthma
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


EBC using metabonomic analysis to assess in holistic way smoking related airway diseases
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Searching for inflammatory and oxidative-stress markers capable of clustering severe asthma.
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018




Overview and history of different ways of assessing and monitoring inflammatory airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017


COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019